Tracer library / [211At]At-antiCD33

[211At]At-antiCD33

Also written as [211At]At-antiCD33
Radionuclide
At-211
Modality
—
Production route
—
Stage
Preclinical
Syntheses indexed
0
Leukemia (acute and chronic)Other radioligand therapy

What it is

Compound class
Radiolabelled anti-CD33 monoclonal antibody (radioimmunoconjugate)
Target / mechanism
CD33 antigen PMID 21789339
Clinical application
Leukaemia (targeted radioimmunotherapy) PMID 21789339
Theranostic pair
—

Published syntheses

No synthesis has been parsed for this agent yet.

Need this precursor?We can point you to suppliers for [211At]At-antiCD33, or handle the enquiry for you.

Get in touch

Notes

Added at stage 39 (2026-09-27) from a reverse search of the PubMed corpus's own unattached articles (articles that named a real compound not yet in this reference): 2 article(s) found under this name, not yet individually researched. Target/mechanism, clinical application, indications, approval, modality, stage and production route are intentionally left empty. PMIDs: 11965231, 21789339. Stage set/updated at stage 39 from PMID 21789339: 'Further development is required to enhance the apparent specific activity and to verify the efficacy in an adequate animal model before phase I clinical studies in leukaemia can be envisaged.'.